DV Biomed Co. Ltd.
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was f… Read more
Market Cap & Net Worth: DV Biomed Co. Ltd. (6539)
DV Biomed Co. Ltd. (TWO:6539) has a market capitalization of $39.30 Million (NT$1.30 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #30716 globally and #1851 in its home market, demonstrating a -4.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DV Biomed Co. Ltd.'s stock price NT$53.40 by its total outstanding shares 24349415 (24.35 Million).
DV Biomed Co. Ltd. Market Cap History: 2015 to 2026
DV Biomed Co. Ltd.'s market capitalization history from 2015 to 2026. Data shows change from $347.33 Million to $39.30 Million (-18.85% CAGR).
DV Biomed Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DV Biomed Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
DV Biomed Co. Ltd.'s market cap is 0.08 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.51x
DV Biomed Co. Ltd.'s market cap is 0.51 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $218.46 Million | $1.93 Billion | $166.28 Million | 0.11x | 1.31x |
| 2020 | $319.05 Million | $1.81 Billion | $301.40 Million | 0.18x | 1.06x |
| 2021 | $291.38 Million | $1.83 Billion | $304.57 Million | 0.16x | 0.96x |
| 2022 | $300.34 Million | $1.87 Billion | $281.26 Million | 0.16x | 1.07x |
| 2023 | $290.48 Million | $618.85 Million | $162.91 Million | 0.47x | 1.78x |
| 2024 | $45.78 Million | $573.57 Million | $89.08 Million | 0.08x | 0.51x |
Competitor Companies of 6539 by Market Capitalization
Companies near DV Biomed Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to DV Biomed Co. Ltd. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
DV Biomed Co. Ltd. Historical Marketcap From 2015 to 2026
Between 2015 and today, DV Biomed Co. Ltd.'s market cap moved from $347.33 Million to $ 39.30 Million, with a yearly change of -18.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$39.30 Million | -9.49% |
| 2025 | NT$43.42 Million | -5.14% |
| 2024 | NT$45.78 Million | -84.24% |
| 2023 | NT$290.48 Million | -3.28% |
| 2022 | NT$300.34 Million | +3.07% |
| 2021 | NT$291.38 Million | -8.67% |
| 2020 | NT$319.05 Million | +46.05% |
| 2019 | NT$218.46 Million | +20.34% |
| 2018 | NT$181.53 Million | -23.75% |
| 2017 | NT$238.07 Million | -39.32% |
| 2016 | NT$392.37 Million | +12.97% |
| 2015 | NT$347.33 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of DV Biomed Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.30 Million USD |
| MoneyControl | $39.30 Million USD |
| MarketWatch | $39.30 Million USD |
| marketcap.company | $39.30 Million USD |
| Reuters | $39.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.